E-mail not displaying correctly? View it in your browser.
Upgrade Your Cell-Based Assays to 3D
Our Products
& Services

Click to find
more about our
 




In this newsletter

Invitation to InSphero workshop “Compound de-risking with 3D-cell-culture systems” - Oct 20 in Boston & Oct 25 in San Francisco, US - few seats left !

Try InSphero's 3D microtissue technology in 2011 with 15% discount!


Meet the InSphero team at the In Vitro Toxicology Society's (IVTS) Annual Meeting - Nov 8-9 in Liverpool, UK

DECHEMA 3D Cell Culture symposium, March 14-16, 2012 in Zurich, Switzerland – call for papers deadline Oct 25


Invitation to InSphero workshop “Compound de-risking with 3D-cell-culture systems” - Oct 20 in Boston & Oct 25 in San Francisco, US - few seats left!
Attending an InSphero workshop is an excellent way to get fully updated with the latest information on 3D-cell-culture technologies for toxicological and efficacy studies. Our expert team and invited guest speakers, with their many years of combined experience, are in a unique position to provide you with information on different approaches to 3D culture and assays and the main issues affecting quality and costs in this segment of the industry today. The next full-day workshops will take place in

- Boston, US, on October 20, 2011 and
- San Francisco, US, on October 25, 2011.

The workshops start at 8:30am. Only a few places left so please register before October 13.

Try InSphero's 3D microtissue technology in 2011 with 15% discount!
Using InSphero’s assay-ready microtissues in your lab is as simple as a conventional 2D cell-based assay. Your workflow and readouts stay largely the same, but the amount and fidelity of information that you can collect is significantly higher. So why not try it right away and see for yourself how easy it is in 2011?
To help you decide, we offer a 15% discount on all assay-ready microtissues (both in oncology and in toxicology) from October 1st, 2011 until December 31st, 2011.
Get in touch with us at sales@insphero.com or give us a phone call on +41-44-515049-0 to receive your individual quotation.

Meet the InSphero team at the In Vitro Toxicology Society's (IVTS) Annual Meeting - Nov 8-9 in Liverpool, UK
Visit the InSphero booth and see our presentations at this event to learn how scaffold-free organotypic 3D liver microtissues, and 3D optimized assays, are boosting the predictive power of in vitro safety testing.
  • Scientific lecture "Toxicology applications of 3D liver models" by S. Messner, during session "Emerging liver cell technologies: stem cells and 3D culture models", please check final program on IVTS website for the date and time
  • Short workshop “Assay your cells in 3D”, please check final program on IVTS website for the date and time

Learn more here.

To arrange a meeting or a webinar please send us an E-mail.

DECHEMA 3D Cell Culture symposium, March 14-16, 2012 in Zurich, Switzerland – call for papers deadline Oct 25
InSphero is supporting this 2.5-day symposium covering the latest developments in 3D-cell-culture technology. The deadline for submission of abstracts and more information can be found on the official symposium website. If you would like to meet InSphero or visit our labs during this event, please let us know in advance.

About InSphero
 

InSphero is a leading supplier of organotypic, biological in-vitro 3D microtissues for highly predictive drug testing. The company, headquartered in Zurich, Switzerland, currently counts 6 of the top ten global pharmaceutical and cosmetics companies as customers, and is helping them implement the company’s patent-pending microtissue technology in their development work-flow. InSphero’s 3D microtissues are scaffold free, highly reproducible and delivered in an automation-compatible 96-well format to replace conventional 2D cell assays for better biological relevance and predictivity. The 3D cancer microtissues reflect tumor physiology and are used routinely for screening. For toxicology and metabolics applications, rat and human 3D liver microtissues predict even rare cases of idiosyncratic toxicology and remain viable for more than 5 weeks for chronic studies. InSphero’s off-the-shelf portfolio of assay-ready microtissues is complemented by custom-made 3D microtissues with a development time of 4-6 weeks and production turnaround of less than 10 days.
InSphero is a spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich. The company was recognized for its scientific and commercial achievements with a number of awards, including the VentureKick award, Heuberger Entrepreneurial Award, CTIstartup certification and the SLAS New Product Award (NPA) 2011 Designation.


Our mailing address is:
InSphero Inc.
74 Orion St
Techplace
Brunswick, ME 04011-5031


Copyright (C) 2011 InSphero Inc. All rights reserved.